
These are our favorite credit cards for Delta flyers in 2025
CNN Underscored reviews financial products based on their overall value. We may receive a commission through our affiliate partners if you apply and are approved for a product, but our reporting is always independent and objective. Terms apply to American Express benefits and offers. Enrollment may be required for select American Express benefits and offers. Visit americanexpress.com to learn more. Delta Air Lines and its Delta SkyMiles loyalty program continue to be a favorite among frequent and casual flyers alike. Known for its extensive route network, impressive onboard entertainment and fast, consistent Wi-Fi, Delta has positioned itself as a premium domestic and international carrier. If you often find yourself flying Delta, the right Delta credit card can elevate your travel experience while helping you rack up SkyMiles faster than ever before.
With multiple personal and business card options issued by American Express and generous welcome offers on many of them, now is an opportune time to find the Delta card that best suits your travel habits.
Delta recently increased annual fees and overhauled benefits on its suite of American Express-cobranded credit cards. So, when choosing a Delta credit card, it's important to consider several key factors beyond just the sign-up bonus.
Travel frequency: Do you fly Delta once or twice a year, or are you hopping on a plane every month? Occasional travelers might benefit most from cards with lower fees, while frequent flyers will see outsized value from premium perks like lounge access and companion certificates.
Elite status goals: Are you aiming to earn or maintain Medallion status? Premium Delta cards can offer MQDs and accelerators that can help.
Checked bags and boarding: Most Delta cards grant your first checked bag free, a benefit that easily offsets a card's annual fee after just a couple of trips. Priority boarding is another perk that enhances the travel experience.
Companion certificates: High-tier Delta cards include annual companion certificates that can provide exceptional value, particularly when used for pricey routes in first class or Comfort+.
Lounge access: If comfort and productivity at the airport are top priorities, look for cards that offer complimentary Delta Sky Club and Centurion Lounge access.
Bonus categories: Consider what you spend the most money on — restaurants, groceries, advertising, shipping? Some cards offer generous miles on categories relevant to both personal and business spending.
Foreign transaction fees: For international travelers, it's important to use a card that doesn't charge foreign transaction fees. Fortunately, all current Delta Amex cards waive these fees.
Delta SkyMiles® Blue American Express Card: Best Delta credit card with no annual fee
Delta SkyMiles® Gold American Express Card: Best for occasional Delta flyers
Delta SkyMiles® Platinum American Express Card: Best for regular Delta flyers
Delta SkyMiles® Reserve American Express Card: Best Delta companion certificate
The Platinum Card® from American Express: Best for Delta lounge access
Delta SkyMiles® Gold Business American Express Card: Best for business owners who fly Delta
Delta SkyMiles® Platinum Business American Express Card: Best for Delta business travelers
Delta SkyMiles® Reserve Business American Express Card: Best for Delta road warriors
Each card comes with its own strengths and trade-offs. In the next sections, we'll take an in-depth look at each and how they stack up against one another.
If you don't fly Delta that often and just want to earn Delta SkyMiles without paying an annual fee, the Delta Blue Amex is a basic, no-frills Delta credit card. With 2 miles earned for every dollar you spend at restaurants worldwide, access to Delta's Pay with Miles program and no foreign transaction fees, this card actually has a decent number of features for an airline credit card in the no-annual-fee camp (see rates and fees).
People who check bags on Delta for at least two trips each year will want a more powerful Delta credit card since the Delta Blue Amex doesn't have a checked bag fee waiver. But for the once-in-a-while traveler, Delta's no-annual-fee credit card may be worth considering.
You can also earn 10,000 bonus miles after you spend $1,000 in purchases on your new Delta Blue Amex card in the first six months after opening your account. Based on the points valuations of frequent flyer website The Points Guy, Delta SkyMiles are worth 1.2 cents apiece, meaning these 10,000 bonus miles are worth $120 toward travel.
Learn more about the Delta SkyMiles Blue Amex Card.
The Delta Gold Amex credit card has an introductory annual fee of $0 for the first year, and then a $150 annual fee starting at your first renewal (see rates and fees), so you can try out the card for a year to see if it's right for you.
New Delta Gold Amex card members can earn 50,000 bonus miles after you spend $2,000 in purchases in the first six months after opening the account. Those miles are worth $600 toward travel based on The Points Guy's valuations.
With the Delta Gold Amex, you'll receive 2 miles per dollar at restaurants and US supermarkets, plus up to $200 in Delta flight credit after spending $10,000 in a calendar year.
You'll also get your first checked bag free on all Delta flights with this card, which further whittles down the net cost of carrying it and offers 20% savings on in-flight purchases made while flying Delta.
Learn more about the Delta SkyMiles Gold Amex Card.
If you've been thinking about getting a Delta Platinum Amex credit card, the card currently features a welcome offer of 60,000 bonus miles after you spend $3,000 in purchases in the first six months after opening the account.
To put it in context, those 60,000 miles are worth $720 based on The Points Guy's valuations, and potentially even more with some simple planning and strategy. Even with the card's $350 annual fee (see rates and fees), you'll easily come out ahead in the first year with just the bonus.
You won't get complimentary lounge access with the Delta Platinum Amex, but you'll still earn 3 miles per dollar spent on eligible Delta purchases and purchases made directly with hotels, 2 miles per dollar at restaurants worldwide and at US supermarkets, and 1 mile per dollar on all other purchases.
Delta Platinum Amex card members also get Zone 5 priority boarding, a domestic main cabin round-trip companion certificate each time you renew the card (starting at the beginning of your second year), your first checked bag free on Delta flights and a Global Entry or TSA PreCheck fee credit worth up to $120.
And if you're chasing Delta elite status, you may also like the Delta Platinum Amex. You'll get a $2,500 Medallion Qualification Dollar (MQD) head start each Medallion qualification year. You'll also earn $1 MQD for every $20 you spend on your card.
Learn more about the Delta SkyMiles Platinum Amex Card.
The Delta Reserve Amex is designed for frequent Delta travelers who are looking for the most premium option. With a $650 annual fee (see rates and fees), this card offers premium benefits tailored to enhance your flying experience and fast-track you toward Medallion status.
One of the card's most valuable features is access to Delta Sky Club lounges. Card members receive 15 visits per Medallion qualification year when flying on Delta. To unlock unlimited Sky Club access, card members must spend $75,000 or more in purchases in a calendar year. You'll also receive four one-time guest passes each year to share the lounge experience with friends or family traveling with you on Delta. And if you pay for your flight with your Reserve card, you'll have access to the Amex Centurion lounge.
The Delta Reserve Amex also comes with a welcome offer of 70,000 bonus miles after spending $5,000 in purchases in the first six months after account opening. Those 70,000 miles are worth $840 at The Points Guy's valuations.
One standout perk is the annual companion certificate. This certificate allows you to bring a travel companion on a round-trip domestic flight in First Class, Comfort+ or Main Cabin; you'll pay no more than $250 in taxes and fees. This benefit can easily offset the card's annual fee when used for a high-value route.
Other travel benefits include:
Complimentary upgrades on Delta flights for Medallion members and even eligible non-elite flyers
First checked bag free on Delta flights
Zone 5 priority boarding
20% back on Delta in-flight purchases
Global Entry or TSA PreCheck application fee credit (up to $120)
Receive $2,500 MQDs per Qualification Year and earn $1 MQD for each $10 with MQD Boost to get closer to status next Medallion year
The card earns 3 miles per dollar on eligible Delta purchases and 1 mile per dollar on everything else.
Learn more about the Delta SkyMiles Reserve Amex Card.
Though it's not a Delta credit card, the Amex Platinum can be a Delta flyer's best friend. You can earn 80,000 Membership Rewards bonus points after you use your new card to make $8,000 in purchases in the first six months after opening the account, and those points are transferable to Delta at a 1-to-1 ratio or to many other airline and hotel partners.
Amex Platinum card members get 10 Delta Sky Club visits per program year (Feb. 1 through Jan. 31) with a same-day Delta boarding pass, with each visit covering all entries within a 24-hour period. Authorized users get their own 10 visits. After that, access is $50 per visit. If you spend $75,000 in a calendar year, you'll unlock unlimited access. Guests aren't free, but up to two can enter for $50 each.
The Amex Platinum also opens the door to Amex's own Centurion Lounges, international American Express lounges, a collection of partner lounges and Priority Pass Select lounges. In total, it unlocks access to more than 1,300 airport lounges across 130 countries (and counting). In other words, the Amex Platinum provides more lounge access but charges a higher $695 annual fee than the Delta Reserve Amex (see rates and fees).
A unique perk of this card is the ability to unlock elite status in a variety of programs. Just by holding the Amex Platinum, you're granted Gold status in Hilton's Honors and Marriott's Bonvoy programs. And on the car rental front, you'll get complimentary memberships in Hertz Gold Plus Rewards, Avis Preferred and National Car Rental Emerald Club Executive. You'll just need to enroll in each of these programs to use this benefit.
For those who rely on ride-sharing to get around, the card comes with $200 in annual statement credits for Uber rides in the US and Uber Eats orders, split into monthly $15 credits, plus a bonus $20 each December. Again, you'll need to enroll before you use this benefit.
You'll also get a credit of up to $120 to cover the fee for applying for either Global Entry or TSA PreCheck, up to $120 in annual Saks Fifth Avenue credits, up to $189 in annual credits toward a CLEAR® membership and up to $200 in annual airline fee credits to cover incidental fees — such as checked bags and in-flight refreshments — on an airline of your choice. Enrollment is also required for each of these benefits.
And let's not forget that the Amex Platinum earns 5 points for every dollar you spend on airfare purchases made directly with any airline (Delta included), as well as on airfare and prepaid hotels booked through amextravel.com.
Learn more about The Platinum Card from American Express.
If you own a business, large or small, Delta also has welcome offers on its line of business credit cards. Currently, you can earn 60,000 bonus miles on the Delta Gold Business card after spending $4,000 in purchases within the first six months after you open the account. The card has a zero-dollar introductory annual fee for the first year, then $150 a year thereafter (see rates and fees).
Similar to the personal Delta Gold Amex, the Delta Gold Business Amex offers up to a $200 Delta flight credit after you spend $10,000 in purchases on your card in a calendar year, plus a free checked bag on Delta flights alongside Zone 5 priority boarding and no foreign transaction fees to sweat (see rates and fees).
However, with this business card, you earn 2 miles per dollar on US shipping and select US advertising purchases (up to $50,000 per category per year) as well as Delta purchases and dining.
Learn more about the Delta SkyMiles Gold Business Amex Card.
The Delta Platinum Business Amex has a $350 annual fee (see rates and fees), but that outlay comes with a welcome offer of 70,000 bonus miles after you spend $6,000 in purchases in the first six months after opening the account.
The card earns 1.5 miles per dollar on eligible transit and US shipping purchases, plus single eligible purchases of $5,000 or more. (Terms and miles cap apply.) If your purchase qualifies for a category that has a higher mileage accelerator, only the higher accelerator will apply.
Flight benefits on the Delta Platinum Business Amex include all the same perks as the personal Delta Platinum Amex card, like a first checked bag for free on Delta flights, Zone 5 priority boarding, no foreign transaction fees (see rates and fees) and the same MQD structure, which can help you earn elite status.
Learn more about the Delta SkyMiles Platinum Business Amex Card.
Business owners willing to pay the card's $650 annual fee (see rates and fees) for the same Delta Sky Club access policy as the Delta Reserve should consider the Delta Reserve Business Amex. Right now, this card offers 80,000 bonus miles after you spend $10,000 in purchases in the first six months after opening the account. You'll earn 3 miles per dollar spent on Delta purchases with the Delta Reserve Business Amex.
As for Medallion status, you'll receive $2,500 MQDs per Qualification Year and earn $1 MQD for each $10 with MQD Boost to get closer to status next Medallion Year.
And finally, the Delta Reserve Business Amex provides complimentary upgrades for non-elite members when available and an annual companion certificate that can be used for domestic first-class travel each year upon renewal of your card. Plus, you won't have to fret over foreign transaction fees (see rates and fees).
Learn more about the Delta SkyMiles Reserve Business Amex Card.
For travelers who fly Delta occasionally and can take advantage of perks like a free checked bag at least twice per year, the Delta Gold Amex or Delta Gold Business Amex may offer solid value without a high annual fee.
If you're aiming to earn elite status with Delta, the Delta Platinum Amex or Platinum Business Amex may be a better fit. These cards help you rack up MQDs, which are central to earning Delta Status.
Frequent travelers who want airport lounge access may prefer the American Express Platinum Card over a Delta Reserve Card. The Amex Platinum offers broader lounge access (including Centurion, Priority Pass and Delta Sky Club), hotel and rental car elite status, and hundreds of dollars in annual credits — all of which help justify its $695 annual fee.
However, if you're loyal to Delta, the Delta Reserve Amex or Delta Reserve Business Amex could be worth it for benefits exclusive to Delta cards, like the annual companion certificate, MQD Headstart and Sky Club perks with guest passes.
The following FAQs have been answered by credit card expert and CNN Underscored travel editor Kyle Olsen.
Which card is better Delta credit card, Gold or Platinum?
Which card is better Delta credit card, Gold or Platinum?
The Delta SkyMiles Platinum Amex is best for frequent Delta flyers who want premium perks like an annual companion ticket, a Global Entry/TSA PreCheck credit and help earning Medallion status, though it comes with a higher annual fee. The Delta Gold Amex is better for occasional travelers looking for solid benefits like a free checked bag and a lower fee. Go with Platinum for maximum rewards or Gold for a budget-friendly option.
Is it possible to upgrade an existing Delta credit card?
Is it possible to upgrade an existing Delta credit card?
Yes, you can upgrade a Delta credit card (like Gold to Platinum or Reserve) by calling American Express or checking your online account. The annual fee will be prorated, but you may not get a welcome bonus. Welcome bonuses are usually for new applicants. For that reason, we suggest applying for a new card instead to earn the full bonus, though upgrading is faster and keeps your current account.
Can you use a Delta credit card for other airlines?
Can you use a Delta credit card for other airlines?
You can use a Delta credit card for purchases on any airline, but perks like bonus miles and travel benefits typically apply only to Delta or its partners. You'll still earn SkyMiles on partner airline flights if you include your SkyMiles number, and you can redeem miles for partner flights, but not directly through other airlines' loyalty programs.
CNN Underscored is committed to providing accurate, unbiased reviews based on in-depth research and real-world testing. As a Delta Gold Elite Medallion member who has covered the ins and outs of Delta's credit cards for years, travel editor Kyle Olsen is a credit cards expert. Our team evaluates credit cards by analyzing value, benefits and how they serve different types of travelers.
Opinions expressed here are the author's alone, not those of any bank, credit card issuer, hotel, airline or other entity. This content has not been reviewed, approved or otherwise endorsed by any of the entities included within the post.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
La Jolla Cosmetic Medical Spa Opens Third Location in Temecula on June 2nd
San Diego's Most Trusted Med Spa Expands to the Inland Empire with Award-Winning Aesthetic Services TEMECULA, Calif., June 5, 2025 /PRNewswire/ -- La Jolla Cosmetic Medical Spa (LJC), a leader in aesthetic care for over three decades, is proud to announce the opening of its third medical spa location in Temecula, California, which opened on Monday, June 2, 2025. This new location brings LJC's award-winning services to the heart of the Temecula Valley. Founded in 1988, the La Jolla Cosmetic brand has been a staple of San Diego's aesthetic community for 35+ years. With medical spa locations in La Jolla and Carlsbad, the practice has earned recognition as an 8-time winner of "Best of San Diego" and is currently named a Top 10 Allergan provider in the nation for injectables like BOTOX® and JUVÉDERM®. Now expanding into Riverside County, LJC continues its mission to make world-class aesthetic care more accessible across Southern California. "Opening in Temecula marks a major milestone in our mission to provide personalized, natural results and build long-term relationships with our patients across Southern California," said Lauren Amico Reed, PA-C, MMS, Co-founder of La Jolla Cosmetic Medical Spa. "We are thrilled to bring our team's expertise and renowned aesthetic care to this incredible community." The Temecula location will offer the full range of LJC's most popular non-surgical services, including: Injectables: BOTOX®, JUVÉDERM®, Sculptra®, and more Skin Rejuvenation: HALO® laser, BBL Hero®, threads, microneedling, and medical-grade facials Hair & Wellness Treatments: Regenerative treatments for hair thinning and sexual wellness injectables Patients can expect the same elevated experience that has made LJC a trusted name in aesthetics—from highly trained providers to personalized treatment plans, all in a welcoming, luxurious setting. With this new location, the brand strengthens its vision of blending clinical excellence with deep community connection. Appointments for the Temecula location can be booked at or by calling (858) 228-4542. To celebrate the launch, LJC is offering an exclusive pre-sale special: 40 units of BOTOX® for $299 for a limited time. Additionally, the official grand opening celebration will be held on Saturday, July 19, from 12 p.m. to 3 p.m. Guests can enjoy: Exciting giveaways Exclusive swag bags for the first arrivals Live treatment demos Light bites and refreshments Fun activities and a chance to tour the new space RSVP: La Jolla Cosmetic Medical Spa – Temecula Grand Opening Event! About La Jolla Cosmetic Medical SpaLa Jolla Cosmetic Medical Spa (LJC) has been helping patients look and feel their best since 2013. Known for delivering natural-looking results through expert providers, advanced technology, and personalized care, LJC sets the standard for aesthetic excellence. With medical spa locations in La Jolla, Carlsbad, and now Temecula, LJC continues to set the standard for aesthetic care in Southern California. View original content to download multimedia: SOURCE La Jolla Cosmetic Medical Spa Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Global Antidote Market to Cross the USD 4 Billion Mark by 2032
The antidote market is witnessing substantial growth, largely propelled by the growing incidence of poisoning, drug overdoses, and snake or animal bites. This rising demand is supported by greater public health awareness, government efforts to combat drug overdoses, and continuous progress in product innovation. Moreover, strategic product launches and technological advancements by key industry players in the treatment of toxicities are further accelerating the market's upward momentum. New York, USA, June 05, 2025 (GLOBE NEWSWIRE) -- Global Antidote Market to Cross the USD 4 Billion Mark by 2032 | DelveInsight The antidote market is witnessing substantial growth, largely propelled by the growing incidence of poisoning, drug overdoses, and snake or animal bites. This rising demand is supported by greater public health awareness, government efforts to combat drug overdoses, and continuous progress in product innovation. Moreover, strategic product launches and technological advancements by key industry players in the treatment of toxicities are further accelerating the market's upward momentum. DelveInsight's Antidote Market Insights report provides the current and forecast market analysis, individual leading antidote companies' market shares, challenges, antidote market drivers, barriers, trends, and key market antidote companies in the market. Key Takeaways from the Antidote Market Report As per DelveInsight estimates, North America is anticipated to dominate the global antidote market during the forecast period. In the antidote type segment of the antidote market, the biological antidotes category accounted for the largest market share in 2024. Notable antidote companies such as Pfizer Inc., SERB Pharmaceuticals, McKesson Corporation, Amneal Pharmaceuticals LLC, EMERGENT, Novartis AG, Troikaa, Hope Pharmaceuticals, Rare Disease Therapeutics, Inc., BTG International Inc., Viatris Inc., Glentham® Life Sciences Limited, Kaleo, Inc., SGPharma Pvt. Ltd., American Regent, Inc., FFF Enterprises, Inc., Amphastar Pharmaceuticals, Inc., Purdue Pharma L.P., Indivior PLC, Harm Reduction Therapeutics, Inc., and several others are currently operating in the antidote market. In August 2024, Purdue Pharma L.P. received FDA approval for the New Drug Application (NDA) of Zurnai™ (nalmefene injection) auto-injector. In March 2024, Indivior PLC announced the results of a pharmacodynamic study showcasing that OPVEE® effectively and rapidly reverses opioid-induced respiratory depression, the primary cause of death in opioid overdoses. This breakthrough demonstrates the potential of OPVEE® as a critical intervention in emergency overdose situations, offering a swift response to prevent life-threatening complications associated with opioid toxicity. To read more about the latest highlights related to the antidote market, get a snapshot of the key highlights entailed in the Global Antidote Market Report Antidote Overview Antidote refers to a substance that counteracts the harmful effects of a poison or toxin. When an individual is exposed to a toxic substance, whether through ingestion, inhalation, injection, or skin contact, an antidote can help neutralize the toxin, reverse its effects, or support the body's natural elimination processes. Antidotes work through various mechanisms: some bind directly to the toxin, others block its biological effects, and some enhance the body's own detoxification systems. Common examples include activated charcoal for many oral poisons, naloxone for opioid overdoses, and atropine for certain nerve agent or pesticide exposures. The development and timely administration of antidotes are crucial in emergency medicine and toxicology. While some antidotes are broadly effective against a wide range of toxins, others are highly specific, targeting a single compound or class of poisons. Due to the diversity of toxic agents and the complexity of their effects on human biology, ongoing research in pharmacology and biochemistry continues to play a critical role in discovering new antidotes. In mass exposure events or cases of rare poisoning, the availability and distribution of appropriate antidotes can be a matter of life and death, underscoring their significance in public health preparedness and clinical Market Insights North America held a substantial share of the antidote market in 2024, fueled by several critical factors. The growing number of poisoning and drug overdose incidents across the region has significantly increased the need for effective antidote solutions. In particular, the opioid epidemic in the United States has driven demand for treatments like naloxone, which can reverse opioid overdoses. Public health campaigns and government-led efforts to curb and manage drug overdoses have further enhanced access to antidotes. Moreover, the market is witnessing a boost from ongoing pharmaceutical innovation and the introduction of new, targeted treatments. In response to this concerning trend, regional authorities have launched various initiatives to address drug overdoses and poisoning. For example, the U.S. Food and Drug Administration (FDA) implemented the Overdose Prevention Framework, which aims to reduce unnecessary opioid prescriptions, encourage harm-reduction strategies through education and innovation, and support the development of evidence-based therapies for substance use disorders and overdoses. Canada is also actively combating the overdose crisis. The Canadian government is investing in prevention programs, expanding access to treatment and harm-reduction services, and leveraging data-driven approaches to guide policy-making. These comprehensive efforts are fostering an environment conducive to the growth of the antidote market across North America. Additionally, pharmaceutical companies in the region are intensifying research and development efforts to bring advanced overdose treatments to market. For instance, in August 2024, Purdue Pharma L.P. received FDA approval for its New Drug Application (NDA) for Zurnai™ (nalmefene injection) auto-injector. This product is designed for emergency use in opioid overdoses caused by both natural and synthetic opioids in adults and adolescents aged 12 and above. The approval of Zurnai™ has expanded the arsenal of available opioid overdose antidotes, offering a fast-acting, user-friendly option to help tackle the ongoing opioid crisis. To know more about why North America is leading the market growth in the antidote market, get a snapshot of the Antidote Market Outlook Antidote Market Dynamics The antidote market is a crucial segment of the global pharmaceutical and toxicology landscape, driven by the increasing incidence of poisoning cases from pharmaceuticals, snake bites, chemical exposure, and overdoses. With growing awareness about drug misuse and rising environmental hazards, the demand for antidotes has surged in both developed and developing countries. Additionally, the rise in hospital admissions due to opioid overdoses, especially in North America and parts of Europe, has directly increased the need for effective and rapid-response antidotes like naloxone. One of the primary market dynamics shaping the antidote sector is the regulatory landscape. Antidotes, often falling under emergency-use drugs, receive fast-track approvals in certain jurisdictions due to their life-saving potential. Governments and healthcare bodies have also begun stockpiling critical antidotes as part of national preparedness programs, especially in regions vulnerable to snake bites or chemical attacks. Furthermore, innovations in biotechnology have allowed the development of more targeted and efficient antidotes, including monoclonal antibodies and small molecule inhibitors tailored for specific toxins or venoms. However, the market faces significant challenges. Many antidotes are expensive to develop and maintain, especially when the target population is small or geographically limited. For example, antivenoms for rare snake species may not be commercially viable due to high R&D costs and limited demand. This has led to a reliance on public-private partnerships and NGO involvement to ensure production and distribution in low-income areas. Moreover, the shelf-life and storage requirements of many antidotes add to supply chain complexity, often limiting their availability in remote or underdeveloped regions. Looking ahead, the antidote market is expected to benefit from increased global focus on public health preparedness and bioterrorism defense. The COVID-19 pandemic underscored the importance of rapid medical response capabilities, prompting governments to revisit their emergency drug inventories. Additionally, as pharmaceutical companies invest in advanced drug delivery systems and synthetic biology, novel antidotes with longer shelf lives and broader efficacy profiles are likely to emerge. The integration of digital health tools and AI in toxicology response systems could also streamline the identification and administration of antidotes, improving patient outcomes and operational efficiency in emergency care. Get a sneak peek at the antidote market dynamics @ Antidote Market Trends Report Metrics Details Coverage Global Study Period 2022–2032 Antidote Market CAGR ~7% Antidote Market Size by 2032 USD 4 Billion Key Antidote Companies Pfizer Inc., SERB Pharmaceuticals, McKesson Corporation, Amneal Pharmaceuticals LLC, EMERGENT, Novartis AG, Troikaa, Hope Pharmaceuticals, Rare Disease Therapeutics, Inc., BTG International Inc., Viatris Inc., Glentham® Life Sciences Limited, Kaleo, Inc., SGPharma Pvt. Ltd., American Regent, Inc., FFF Enterprises, Inc., Amphastar Pharmaceuticals, Inc., Purdue Pharma L.P., Indivior PLC, Harm Reduction Therapeutics, Inc., among others Antidote Market Assessment Antidote Market Segmentation Antidote Market Segmentation By Type: Chemical Antidotes and Biological Antidotes Antidote Market Segmentation By Route of Administration: Oral and Parenteral Antidote Market Segmentation By Distribution Channel: Hospital and Retail Pharmacies Antidote Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View Which MedTech key players in the antidote market are set to emerge as the trendsetter explore @ Antidote Companies Table of Contents 1 Antidote Market Report Introduction 2 Antidote Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 Antidote Market Key Factors Analysis 6 Antidote Market Porter's Five Forces Analysis 7 Antidote Market Layout 8 Antidote Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us Interested in knowing the antidote market by 2032? Click to get a snapshot of the Antidote Market Analysis Related Reports Heavy Metal Poisoning Market Heavy Metal Poisoning Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key heavy metal poisoning companies, including EmeraMed, Magellan Diagnostics, Bezoloven Inc., among others. Substance Use Disorder Market Substance Use Disorder Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key SUD companies including BioXcel Therapeutics, NFL Biosciences, STALICLA, Embera NeuroTherapeutics, PleoPharma, Kinnov Therapeutics, Imbrium Therapeutics, Atai Life Sciences, Beckley Psytech, among others. Opioid Use Disorder Market Opioid Use Disorder Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key OUD companies including Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, BioDelivery Sciences International Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, Camurus, among others. Cocaine Use Disorder Market Cocaine Use Disorder Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key CUD companies including STALICLA, Embera NeuroTherapeutics, among others. Cocaine Intoxication Market Cocaine Intoxication Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key cocaine intoxication companies including Tonix Pharmaceutical, among others. DelveInsight's Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion. Other Business Pharmaceutical Consulting Services Healthcare Conference Coverage Pipeline Assessment Healthcare Licensing Services Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study About DelveInsight DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. CONTACT: Contact Us Shruti Thakur info@ +14699457679Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ('Treace' or the 'Company') (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® procedures, today announced that it filed a lawsuit against Zimmer Biomet Holdings, Inc. and Paragon 28, Inc. (collectively, 'Zimmer') (NYSE: ZBH), alleging infringement of 4 patents related to Treace's innovative Lapiplasty® 3D Bunion Correction® technologies. The suit was filed in the United States District Court for the District of Delaware, and seeks injunctive relief and damages. 'Treace Medical was the first company to develop, patent, and introduce an instrumented 3D bunion correction system for true tri-planar lapidus bunion correction and is the recognized leader in the surgical treatment of bunions. We believe that this lawsuit is necessary to protect the significant investments we have made in our pioneering research and technology, which is in the best interest of our stockholders,' said John T. Treace, Chairman, CEO and Founder of Treace. 'Enforcing and defending our intellectual property helps to drive our ability to continue to innovate solutions that benefit patients.' Treace's patent portfolio includes 80 granted U.S. patents, with an additional 26 granted patents worldwide and over 150 pending patent applications. About Treace Medical Concepts Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion and related midfoot deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans, of which Treace estimates 1.1 million are annual surgical candidates. Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. To further support the needs of bunion patients, Treace has introduced its Adductoplasty® Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP™ Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty™ 3D Minimally Invasive Bunion Correction System and the Percuplasty™ Percutaneous 3D Bunion Correction System. The Company continues to expand its footprint in the foot and ankle market with the introduction of its SpeedPlate™ Rapid Compression Implants, an innovative fixation platform with broad versatility across Lapiplasty® and Adductoplasty® procedures, as well as other common bone fusion procedures of the foot. For more information, please visit To learn more about Treace, connect with us on LinkedIn, X, Facebook and Instagram. Contacts:Treace Medical ConceptsMark L. HairChief Financial Officermhair@ 373-5940 Investors:Gilmartin GroupPhilip Trip Taylor IR@